Nuvalent, Inc. ($NUVL)
Filing Information
| Accession Number | 0001193125-26-006571 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
42,417
Total Value
$721,320.39
P&L
+inf% (+$3,316,950.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 871 | $96.06 | $83,668.26 | 61,676 | Direct | โ | View Details | |
Chief Medical Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 1,119 | $96.85 | $108,375.15 | 60,557 | Direct | โ | View Details | |
Chief Medical Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 1,929 | $97.96 | $188,964.84 | 58,628 | Direct | โ | View Details | |
Chief Medical Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 317 | $98.52 | $31,230.84 | 58,311 | Direct | โ | View Details | |
Chief Medical Officer | Class A Common Stock | โ | Jan 6, 2026 | Sale | 1,321 | $96.75 | $127,806.75 | 56,990 | Direct | โ | View Details | |
Chief Medical Officer | Class A Common Stock | โ | Jan 6, 2026 | Sale | 1,635 | $97.33 | $159,134.55 | 55,355 | Direct | โ | View Details | |
Chief Medical Officer | Class A Common Stock | โ | Jan 6, 2026 | Sale | 225 | $98.40 | $22,140.00 | 55,130 | Direct | โ | View Details | |
Chief Medical Officer | Class A Common Stock | โ | Jan 7, 2026 | Grant/Award | 17,500 | $0.00 | $0.00 | 72,630 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Grant/Award | 17,500 | $0.00 | $0.00 | 17,500 | Direct | โ | View Details |